JFS Wealth Advisors LLC lowered its stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 2.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,667 shares of the company’s stock after selling 572 shares during the quarter. JFS Wealth Advisors LLC’s holdings in Procter & Gamble were worth $4,806,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Concurrent Investment Advisors LLC grew its stake in Procter & Gamble by 4.5% in the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after buying an additional 4,035 shares during the last quarter. Copley Financial Group Inc. acquired a new stake in shares of Procter & Gamble in the third quarter valued at about $668,000. Fortem Financial Group LLC acquired a new stake in shares of Procter & Gamble in the fourth quarter valued at about $569,000. Richard C. Young & CO. LTD. increased its stake in shares of Procter & Gamble by 2.1% in the fourth quarter. Richard C. Young & CO. LTD. now owns 123,853 shares of the company’s stock worth $20,764,000 after purchasing an additional 2,568 shares during the period. Finally, Nordea Investment Management AB lifted its position in shares of Procter & Gamble by 7.5% during the 4th quarter. Nordea Investment Management AB now owns 2,898,569 shares of the company’s stock worth $484,583,000 after purchasing an additional 201,695 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
Analysts Set New Price Targets
PG has been the topic of several recent analyst reports. DA Davidson reaffirmed a “buy” rating and issued a $209.00 price target on shares of Procter & Gamble in a research report on Thursday, January 23rd. JPMorgan Chase & Co. cut their target price on shares of Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating for the company in a research note on Thursday, January 16th. Evercore ISI raised their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research report on Monday, October 21st. Barclays upped their price objective on shares of Procter & Gamble from $155.00 to $159.00 and gave the company an “equal weight” rating in a research report on Thursday, January 23rd. Finally, Wells Fargo & Company boosted their price target on Procter & Gamble from $176.00 to $180.00 and gave the company an “overweight” rating in a research note on Thursday, January 23rd. Eight equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and an average target price of $180.53.
Insider Activity
In related news, insider Marc S. Pritchard sold 90,450 shares of the firm’s stock in a transaction dated Thursday, January 23rd. The stock was sold at an average price of $163.84, for a total value of $14,819,328.00. Following the transaction, the insider now owns 172,814 shares in the company, valued at $28,313,845.76. This trade represents a 34.36 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $172.73, for a total value of $2,210,944.00. Following the sale, the insider now directly owns 11,595 shares of the company’s stock, valued at $2,002,804.35. This represents a 52.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 151,097 shares of company stock valued at $25,635,076 over the last three months. 0.18% of the stock is owned by insiders.
Procter & Gamble Stock Down 4.8 %
Shares of PG opened at $162.84 on Monday. The company has a market capitalization of $381.84 billion, a P/E ratio of 25.93, a PEG ratio of 3.79 and a beta of 0.45. The Procter & Gamble Company has a one year low of $153.52 and a one year high of $180.43. The business’s 50 day simple moving average is $166.51 and its 200-day simple moving average is $169.46. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.76 and a quick ratio of 0.55.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its earnings results on Wednesday, January 22nd. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.86 by $0.02. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The company had revenue of $21.88 billion for the quarter, compared to analysts’ expectations of $21.66 billion. During the same quarter in the prior year, the business earned $1.84 earnings per share. The business’s revenue for the quarter was up 2.1% on a year-over-year basis. As a group, sell-side analysts predict that The Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th will be given a dividend of $1.0065 per share. The ex-dividend date of this dividend is Friday, January 24th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.47%. Procter & Gamble’s payout ratio is 64.17%.
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
- Five stocks we like better than Procter & Gamble
- Investing in the High PE Growth Stocks
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- Trading Stocks: RSI and Why it’s Useful
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- What Does Downgrade Mean in Investing?
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.